Chi Advisors LLC Pliant Therapeutics, Inc. Call Options Transaction History

Chi Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $104,976 - $145,080	7,200 Added 5.53%	137,500 $2.38 Million
Q2 2023 Aug 11, 2023	BUY	$18.12 - $30.56 $2.36 Million - $3.98 Million	130,300 New	130,300 $2.36 Million
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $510,000 - $762,900	30,000 New	30,000 $579,000

127

57.7M

245K

86.7K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $84.2M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.